Delivery strategies for antisense oligonucleotide therapeutics:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boca Raton [u.a.]
CRC Press
1995
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 305 S. Ill., graph. Darst. |
| ISBN: | 0849347785 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010467391 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 951109s1995 ad|| |||| 00||| eng d | ||
| 020 | |a 0849347785 |9 0-8493-4778-5 | ||
| 035 | |a (OCoLC)31331532 | ||
| 035 | |a (DE-599)BVBBV010467391 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a RM666.A564 | |
| 082 | 0 | |a 615/.31 |2 20 | |
| 084 | |a WD 5350 |0 (DE-625)148200: |2 rvk | ||
| 245 | 1 | 0 | |a Delivery strategies for antisense oligonucleotide therapeutics |c ed. by Saghir Akhtar |
| 264 | 1 | |a Boca Raton [u.a.] |b CRC Press |c 1995 | |
| 300 | |a 305 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Antisense nucleic acids |x Therapeutic use | |
| 650 | 4 | |a Drugs |x Dosage forms | |
| 650 | 4 | |a Oligonucleotides |x Therapeutic use | |
| 650 | 4 | |a Oligonucleotides, Antisense |x pharmacology | |
| 650 | 4 | |a Oligonucleotides, Antisense |x therapeutic use | |
| 650 | 0 | 7 | |a Antisense-Oligonucleotide |0 (DE-588)4371006-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Heilmittel |0 (DE-588)4024069-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Antisense-Oligonucleotide |0 (DE-588)4371006-2 |D s |
| 689 | 0 | 1 | |a Heilmittel |0 (DE-588)4024069-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Akhtar, Saghir |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006975190&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006975190 | ||
Datensatz im Suchindex
| _version_ | 1804124900587208704 |
|---|---|
| adam_text | DELIVERY STRATEGIES FOR ANTISENSE OLIGONUCLEOTIDE THERAPEUTICS EDITED BY
SAGHIR AKHTAR CRC PRESS BOCA RATON NEW YORK LONDON TOKYO TABLE OF
CONTENTS PREFACE SECTION 1 OVERVIEW OF ANTISENSE OLIGONUCLEOTIDE
THERAPEUTICS AND DELIVERY CHAPTER 1 DISRUPTING THE FLOW OF GENETIC
INFORMATION WITH ANTISENSE OLIGODEOXYNUCLEOTIDES: RESEARCH AND
THERAPEUTIC APPLICATIONS, D. KREGENOW, M.Z. RATAJECZAK, AND A. GEWIRTZ 1
CHAPTER 2 CELLULAR DELIVERY OF RIBOZYMES, D.A. ELKINS AND J.J. ROSSI 17
CHAPTER 3 IMPROVED STRUCTURAL DESIGN AND CELLULAR UPTAKE OF
TRIPLEX-FORMING OLIGONUCLEOTIDES, N. CHAUDHARY, J.S. BISHOP, K.
JAYARAMAN, AND J.K. GUY-CAFFEY 39 SECTION 2 PHARMACOKINETIC AND
DISTRIBUTION STUDIES CHAPTER 4 PHARMACOKINETICS AND DELIVERY OF
OLIGONUCLEOTIDES TO THE BRAIN, L. NECKERS, D.A. GESELOWITZ, AND C.
CHAVANY 61 CHAPTER 5 IN VIVO PHARMACOKINETICS OF OLIGONUCLEOTIDES
FOLLOWING ADMINISTRATION BY DIFFERENT ROUTES, V.V. VLASSOV, L.A.
YAKUBOV, V. KARAMYSHEV, L. PAUTOVA, E. RYKOVA, AND M. NECHAEVA 71
SECTION 3 IMPROVING BIOLOGICAL STABILITY OF OLIGONUCLEOTIDES CHAPTER 6
NUCLEASE-RESISTANT DNA THERAPEUTICS, E. WICKSTROM 85 CHAPTER 7
SELF-STABILIZED OLIGONUCLEOTIDES AS NOVEL ANTISENSE AGENTS, S. AGRAWAL,
J. TEMSAMANI, AND J. TANG 105 CHAPTER 8 CIRCULAR OLIGONUCLEOTIDES AS
POTENTIAL MODULATORS OF GENE EXPRESSION, E.T. KOOL 123 CHAPTER 9 PEPTIDE
NUCLEIC ACIDS AS ANTISENSE THERAPEUTIC AGENTS, L.C. HANVEY AND L.E.
BABISS 151 CHAPTER 10 STABILIZED RNA ANALOGS FOR ANTISENSE AND RIBOZYME
APPLICATIONS, H. AURUP, O. HEIDENREICH, AND F. ECKSTEIN 161 SECTION 4
IMPROVING MEMBRANE TRANSPORT AND TARGETED DELIVERY OF ANTISENSE
OLIGONUCLEOTIDES CHAPTER 11 UPTAKE AND LOCALIZATION OF PHOSPHODIESTER
AND CHIMERIC OLIGODEOXYNUCLEOTIDES IN NORMAL AND LEUKEMIC PRIMARY CELLS,
A. KRIEG 177 CHAPTER 12 OLIGONUCLEOTIDE TRANSPORT ACROSS MEMBRANES AND
INTO CELLS: EFFECTS OF CHEMICAL MODIFICATIONS, J. HUGHES, A.
AVROIITSKAYA, H. M. SASMOR, C.J. GUINOSSO, P.D. COOK, AND R.L. JULIANO
191 CHAPTER 13 LIPOSOMES AS A DELIVERY SYSTEM FOR ANTISENSE AND RIBOZYME
COMPOUNDS, A.R. THIERRY AND G.B. TAKLE 199 CHAPTER 14 INTRACELLULAR
DELIVERY OF OLIGONUCLEOTIDES WITH CATIONIC LIPOSOMES, C.F. BENNETT 223
CHAPTER 15 THE DELIVERY OF OLIGONUCLEOTIDES USING PH-SENSITIVE
LIPOSOMES, C. ROPERT, P. COUVREUR, AND C. MALVY 233 CHAPTER 16 ENHANCING
ENDOSOMAL EXIT OF NUCLEIC ACIDS USING PH-SENSITIVE VIRAL FUSION
PEPTIDES, B. OBERHAUSER, C. PLANK AND E. WAGNER 247 CHAPTER 17 TARGETED
DELIVERY OF ANTI-HEPATITIS B ANTISENSE OLIGONUCLEOTIDES, E.P.
CARMICHAEL, H.C. CHIOU, M.A. FINDEIS, G.L. SPITALNY AND J.R. MERWIN 267
CHAPTER 18 DESIGN, SYNTHESIS, AND CELLULAR DELIVERY OF
ANTIBODY-ANTISENSE OLIGONUCLEOTIDE CONJUGATES FOR CANCER THERAPY, C.S.R.
GOODEN AND A.A. EPENETOS 283 INDEX 295
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV010467391 |
| callnumber-first | R - Medicine |
| callnumber-label | RM666 |
| callnumber-raw | RM666.A564 |
| callnumber-search | RM666.A564 |
| callnumber-sort | RM 3666 A564 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | WD 5350 |
| ctrlnum | (OCoLC)31331532 (DE-599)BVBBV010467391 |
| dewey-full | 615/.31 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.31 |
| dewey-search | 615/.31 |
| dewey-sort | 3615 231 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01624nam a2200421 c 4500</leader><controlfield tag="001">BV010467391</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">951109s1995 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0849347785</subfield><subfield code="9">0-8493-4778-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31331532</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010467391</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.A564</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.31</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WD 5350</subfield><subfield code="0">(DE-625)148200:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Delivery strategies for antisense oligonucleotide therapeutics</subfield><subfield code="c">ed. by Saghir Akhtar</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton [u.a.]</subfield><subfield code="b">CRC Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">305 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antisense nucleic acids</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Dosage forms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oligonucleotides</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oligonucleotides, Antisense</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oligonucleotides, Antisense</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antisense-Oligonucleotide</subfield><subfield code="0">(DE-588)4371006-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Heilmittel</subfield><subfield code="0">(DE-588)4024069-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antisense-Oligonucleotide</subfield><subfield code="0">(DE-588)4371006-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Heilmittel</subfield><subfield code="0">(DE-588)4024069-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Akhtar, Saghir</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006975190&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006975190</subfield></datafield></record></collection> |
| id | DE-604.BV010467391 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:53:01Z |
| institution | BVB |
| isbn | 0849347785 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006975190 |
| oclc_num | 31331532 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 305 S. Ill., graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | CRC Press |
| record_format | marc |
| spelling | Delivery strategies for antisense oligonucleotide therapeutics ed. by Saghir Akhtar Boca Raton [u.a.] CRC Press 1995 305 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antisense nucleic acids Therapeutic use Drugs Dosage forms Oligonucleotides Therapeutic use Oligonucleotides, Antisense pharmacology Oligonucleotides, Antisense therapeutic use Antisense-Oligonucleotide (DE-588)4371006-2 gnd rswk-swf Heilmittel (DE-588)4024069-1 gnd rswk-swf Antisense-Oligonucleotide (DE-588)4371006-2 s Heilmittel (DE-588)4024069-1 s DE-604 Akhtar, Saghir Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006975190&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Delivery strategies for antisense oligonucleotide therapeutics Antisense nucleic acids Therapeutic use Drugs Dosage forms Oligonucleotides Therapeutic use Oligonucleotides, Antisense pharmacology Oligonucleotides, Antisense therapeutic use Antisense-Oligonucleotide (DE-588)4371006-2 gnd Heilmittel (DE-588)4024069-1 gnd |
| subject_GND | (DE-588)4371006-2 (DE-588)4024069-1 |
| title | Delivery strategies for antisense oligonucleotide therapeutics |
| title_auth | Delivery strategies for antisense oligonucleotide therapeutics |
| title_exact_search | Delivery strategies for antisense oligonucleotide therapeutics |
| title_full | Delivery strategies for antisense oligonucleotide therapeutics ed. by Saghir Akhtar |
| title_fullStr | Delivery strategies for antisense oligonucleotide therapeutics ed. by Saghir Akhtar |
| title_full_unstemmed | Delivery strategies for antisense oligonucleotide therapeutics ed. by Saghir Akhtar |
| title_short | Delivery strategies for antisense oligonucleotide therapeutics |
| title_sort | delivery strategies for antisense oligonucleotide therapeutics |
| topic | Antisense nucleic acids Therapeutic use Drugs Dosage forms Oligonucleotides Therapeutic use Oligonucleotides, Antisense pharmacology Oligonucleotides, Antisense therapeutic use Antisense-Oligonucleotide (DE-588)4371006-2 gnd Heilmittel (DE-588)4024069-1 gnd |
| topic_facet | Antisense nucleic acids Therapeutic use Drugs Dosage forms Oligonucleotides Therapeutic use Oligonucleotides, Antisense pharmacology Oligonucleotides, Antisense therapeutic use Antisense-Oligonucleotide Heilmittel |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006975190&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT akhtarsaghir deliverystrategiesforantisenseoligonucleotidetherapeutics |